Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMP22 | Q01453 | 2/20 | 0.59 |
| ▸ | GSR | P00390 | 2/20 | 0.52 |
| ▸ | GRM8 | O00222 | 1/20 | 0.52 |
| ▸ | GRM6 | O15303 | 1/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.52 |
| ▸ | GRM5 | P41594 | 1/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.52 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.52 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.52 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.52 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.52 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.52 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9193067 | 1.00 | PMP22 (0.59) | PMP22GSRGRM8GRM6GRIN2D | |
| SCHEMBL157694 | 1.00 | PMP22 (0.59) | PMP22GSRGRM8GRM6GRIN2D | |
| Bromide SCHEMBL8445234 | 0.98 | PMP22 (0.57) | PMP22GSRGRM8GRM6GRIN2D | |
| Hydrochloric Acid SCHEMBL26699118 | 0.98 | PMP22 (0.57) | PMP22GSRGRM8GRM6GRIN2D | |
| SCHEMBL28766377 | 0.98 | PMP22 (0.57) | PMP22GSRGRM8GRM6GRIN2D | |
| Hydrochloric Acid SCHEMBL26699117 | 0.98 | PMP22 (0.57) | PMP22GSRGRM8GRM6GRIN2D | |
| Bromide SCHEMBL8445230 | 0.98 | PMP22 (0.57) | PMP22GSRGRM8GRM6GRIN2D | |
| Homocysteine SCHEMBL27998293 | 0.89 | PMP22 (0.50) | PMP22GSRGRM8GRM6GRIN2D | |
| SCHEMBL38660644 | 0.89 | GSR (0.54) | PMP22GSRGRM8GRM6GRIN2D | |
| Lysine SCHEMBL1080025 | 0.86 | GSR (0.74) | PMP22GSRCYP1A2BLMARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1770 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103499-A1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | HAN JIE (US) | 2026-04-16 | — | — | US | claimed |
| EP-3986363-B1 | FORMULATIONS FOR ODONTOLOGICAL AND DERMATOLOGICAL USE CONTAINING TRICHLOROACETATE SALTS AND HYDROXYACIDS | WIQO S P A (IT) | 2025-12-03 | — | — | EP | claimed |
| EP-3956355-B1 | STABILIZATION OF PRANDIAL OR BASAL INSULIN ANALOGUES BY AN INTERNAL DISELENIDE BRIDGE | UNIV INDIANA TRUSTEES (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3448417-B1 | INSULIN DIMER-INCRETIN CONJUGATES | MERCK SHARP & DOHME LLC (US) | 2025-11-12 | — | — | EP | claimed |
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SENSEONICS, INCORPORATED (US) | 2025-09-23 | — | — | US | claimed |
| EP-3880688-B1 | OLIGOSACCHARIDE PREPARATIONS AND COMPOSITIONS | DSM IP ASSETS BV (NL) | 2025-09-17 | — | — | EP | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025065271-A1 | METHODS AND DEVICES FOR TREATING DEPRESSION | Liangzhu Laboratory (CN) | 2025-04-03 | — | — | WO | claimed |
| EP-3965657-B1 | MEDIATION OF IN VIVO ANALYTE SIGNAL DEGRADATION | SENSEONICS INC (US) | 2025-03-05 | — | — | EP | claimed |
| US-20250051416-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME LLC (US) | 2025-02-13 | — | — | US | claimed |
| EP-0336387-A2 | Process for producing L-arginine | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) | 1989-10-11 | — | — | EP | claimed |
| US-4412943-A | CONTAINING AN ALKYLENEDIAMINE CARBOXYLIC ACID DERIVATIVE AND AN AMMONIUM SULFATE | KAO SOAP CO., LTD. (JP) | 1983-11-01 | — | — | US | claimed |
| US-4302593-A | RECOVERING THE AMINO ACID FROM THE COMPOUND AS A MEANS OF SEPARATION OR PURIFICATION FROM SOLUTION | LOWE ORVILLE G | 1981-11-24 | — | — | US | claimed |
| US-4283386-A | APPLYING A CYSTEIC ACID COMPOUND AND A METALLIC COMPOUND | SCOTT EUGENE J VAN | 1981-08-11 | — | — | US | claimed |
| US-4273684-A | Transparent detergent bar | AJINOMOTO CO., INC. (JP) | 1981-06-16 | — | — | US | claimed |
| US-4246261-A | HYDROXY ACIDS, ESTERS, LACTONES | SCOTT EUGENE J VAN | 1981-01-20 | — | — | US | claimed |
| US-4228304-A | ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, ANTIULCER AGENTS, BACTERICIDES, ANTITHROMBOTIC AGENTS AND FOR LIVER DISORDERS, OR AS SURFACTANTS IN DETERGENTS AND OIL ADDITIVES | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 1980-10-14 | — | — | US | claimed |
| US-4224339-A | Treatment of disturbed keratinization | SCOTT EUGENE J VAN | 1980-09-23 | — | — | US | claimed |
| US-4053630-A | FOR ACNE, DANDRUFF AND ICTHYOTIC SKIN CONDITIONS; CYSTEIC, HOMOCYSTEIC, CYSTEINESULFINIC ACID OR METAL CHELATES THEREOF | YU RUEY J | 1977-10-11 | — | — | US | claimed |
| US-3985722-A | Process for preparing N-higher aliphatic acyl derivatives of amino acids, peptides or proteins | AJINOMOTO CO., INC. (JA) | 1976-10-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419551-B2 | Mediation of in vivo analyte signal degradation | SLC2A1, TXN2, SLC2A8 | PMP22 3284/4885GSR 41/4885GRM8 615/4885 |
| US-20260103499-A1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | CBR1, CBR3, SIGMAR1 | PMP22 2621/4885GSR 143/4885GRM8 2965/4885 |
| US-20250051416-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | INSR, GPR119, IRS1 | PMP22 4457/4885GSR 1243/4885GRM8 407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.